Zai Lab Ltd (HK:9688) has released an update.
Zai Lab Limited, a biopharmaceutical company, has announced that its Audit Committee will approve and publish the unaudited condensed consolidated results for the first half of 2024 on August 26/27, 2024. These interim financial results will comply with Hong Kong Listing Rules, including a reconciliation from U.S. GAAP to International Financial Reporting Standards, and follow the company’s recent filing of its quarterly report with the SEC.
For further insights into HK:9688 stock, check out TipRanks’ Stock Analysis page.
